Clinical trial
Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With…
NCT00044785 · Wellstat Therapeutics, Industry · Terminated
Key facts
| NCT number | NCT00044785 |
|---|---|
| Title | Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors |
| Official title | A Phase I Study of Escalating Doses of CPT-11 and 5fluorouracil (5FU) Plus PN401 With a Fixed Dose of Leucovorin in Patients With Solid Tumor Malignancies. |
| Lead sponsor | Wellstat Therapeutics, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Solid Tumors |
| Intervention type | Drug |
| Interventions | triacetyluridine, fluorouracil, leucovorin, camptosar |
| Enrollment | 24 |
| Start date | Aug 1, 2002 |
| Completion | Mar 1, 2004 |
| First posted | Sep 6, 2002 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: